+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genome Editing: Technologies and Global Markets

  • ID: 3647021
  • Report
  • Region: Global
  • 148 Pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • Addgene
  • Atum (Dna2.0)
  • Calyxt Inc.
  • Crispr Therapeutics
  • Ixcells Biotechnologies
  • Sangamo Biosciences
  • MORE
Report Scope:

This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of World.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market’s growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

The Report Includes:
  • 44 tables
  • A comprehensive overview of the global markets and technologies for genome editing within the industry
  • Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
  • Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
  • Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
  • Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
  • Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Addgene
  • Atum (Dna2.0)
  • Calyxt Inc.
  • Crispr Therapeutics
  • Ixcells Biotechnologies
  • Sangamo Biosciences
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

  • Key Drivers of Market Growth

Chapter 3 Current Genome Editing Technologies

  • Overview
  • History of Genome Editing
  • Comparison of Genome Editing
  • Discovery of CRISPR-Cas9
  • Components of CRISPR-Cas Systems
  • SgRNA
  • Cas9 Nucleases
  • How CRISPR-Cas Works
  • Advantage of the CRISPR-Cas9 System
  • Popularity of CRISPR Genome Editing
  • Major Technological Issues
  • Efficiency
  • Specificity/Off-Target Effect
  • Delivery Systems
  • Immunogenicity Risk for Clinical Applications
  • A New Genome Editing System: CRISPR-Cpf1
  • Studies on Treating Diseases Using Genome Editing
  • Impact of Genome Editing
  • Future of CRISPR

Chapter 4 Applications of Genome Editing

  • Introduction
  • Academic Research
  • Drug Discovery and Development
  • Clinical Therapy
  • Non-transgenic Breeding
  • Diagnostics
  • Other Applications

Chapter 5 Market Segmentation and Forecast

  • Market Overview
  • Major Players
  • Market Segments by Region
  • Market Segments by Application
  • Market Segments by Technology
  • Market Segments by Product Type

Chapter 6 Contract Services Market Analysis

  • Market Overview
  • Major Players
  • Market Share and Projection
  • Comparison with Products Segment

Chapter 7 Research Market Analysis

  • Market Overview
  • Market Share and Projections
  • Patent Analysis
  • Publication Analysis
  • Research Funding Analysis

Chapter 8 Drug Development Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 9 Agricultural Biotechnology Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 10 Clinical Market Analysis

  • Market Overview
  • Market Share and Forecast
  • Comparison with Non-clinical Market

Chapter 11 Competition Landscape and Opportunities

  • Overview
  • Growth Strategies
  • Licensing and Agreements
  • Collaborations with Big Biopharmaceutical Companies
  • In-house R&D Program
  • Startup
  • Strategic Alliance and Joint Venture
  • Focus on Specific Application Areas
  • Venture Capital Funding
  • Opportunities

Chapter 12 Factors Influencing the Genome Editing Market

  • Introduction
  • Driving Forces
  • New Genome Editing Technologies and Related Advancements
  • New Applications of Genome Editing
  • Need for Precision Medicine
  • Need for Improving Drug Discovery Process
  • Increasing Demand for Synthetic Genes in Synthetic Biology
  • Investments from Both Public and Private Sectors
  • Increased R&D Expenditures in Related Industrial Sectors
  • High Prevalence of Genetic Birth Disorders
  • Concerns on Genetically Modified Crops
  • Factors Limiting the Market’s Growth
  • Stringent Regulatory Frameworks and Time-Consuming Approval Processes
  • Research Funding
  • Patent Disputes
  • Governmental Policies and Regulations
  • Regulatory Uncertainty on Genome Edited Crops
  • Ethical Issues

Chapter 13 Company Profiles

  • Addgene
  • Agilent Technologies Inc.
  • Aldevron
  • Allele Biotechnology
  • American Type Culture Collection (Atcc)
  • Applied Stemcell Inc.
  • Arbor Biotechnologie Inc.
  • Astrazeneca
  • Atum (Dna2.0)
  • Australian Bioresources Ltd.
  • Axol Bioscience Ltd.
  • Beam Therapeutics
  • Biocytogen
  • Bio-Rad Laboratories Inc.
  • Biotools Co. Ltd.
  • Bluebird Bio
  • B-Mogen Biotechnologies Inc.
  • Calyxt Inc.
  • Canopy Biosciences
  • Caribou Biosciences Inc.
  • Caszyme
  • Cellecta Inc.
  • Cellectics S.A.
  • Cibus
  • Crispr Therapeutics
  • Desktop Genetics
  • Editas Medicine
  • Genecopoeia
  • Genewiz
  • Genscript
  • Horizon Discovery
  • Innovative Genomics Initiative
  • Intellia Therapeutics Inc.
  • Integrated Dna Technologies
  • Ixcells Biotechnologies
  • Juno Therapeutics
  • Lonza
  • Mammoth Biosciences
  • Merck Kgaa (Sigma-Aldrich)
  • New England Biolabs
  • Origene Technologies
  • Precision Biosciences Inc.
  • Recombinetics
  • Regeneron Pharmaceutals Inc.
  • Sangamo Biosciences
  • Solentim Inc.
  • Synthego
  • System Biosciences
  • Takara Bio Usa Inc. (Clontech)
  • Thermo Fisher Scientific
  • Toolgen Inc.
  • Trans Genic Inc.
  • Transomic Technologies Inc.
  • Transposagen Biopharmaceuticals Inc.
  • Vertex Pharmaceuticals Inc.

List of Tables
Summary Table: Global Market for Genome Editing, by Region, Through 2023
Table 1: Major Companies That Have Business Related to Genome Editing, July 2018
Table 2: Distribution of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
Table 3: Distribution of Companies That Have Genome-Editing-Related Businesses, by U.S. State, July 2018
Table 4: Global Market for Genome Editing, by Region, Through 2023
Table 5: Global Market for Genome Editing, by Application, Through 2023
Table 6: U.S. Market for Genome Editing, by Application, Through 2023
Table 7: European Market for Genome Editing, by Application, Through 2023
Table 8: Asia-Pacific Market for Genome Editing, by Application, Through 2023
Table 9: Rest of World Market for Genome Editing, by Application, Through 2023
Table 10: Global Market for Genome Editing, by Technology, Through 2023
Table 11: U.S. Market for Genome Editing, by Technology, Through 2023
Table 12: European Market for Genome Editing, by Technology, Through 2023
Table 13: Asia-Pacific Market for Genome Editing, by Technology, Through 2023
Table 14: Rest of World Market for Genome Editing, by Technology, Through 2023
Table 15: Global Market for Genome Editing, by Product Type, Through 2023
Table 16: U.S. Market for Genome Editing, by Product Type, Through 2023
Table 17: European Market for Genome Editing, by Product Type, Through 2023
Table 18: Asia-Pacific Market for Genome Editing, by Product Type, Through 2023
Table 19: Rest of World Market for Genome Editing, by Product Type, Through 2023
Table 20: Major Companies That Provide Genome-Editing-Related Services, July 2018
Table 21: Global Market for Genome Editing Services, by Region, Through 2023
Table 22: Global Market for Genome Editing, by Product Segment, Through 2023
Table 23: U.S. Market for Genome Editing, by Product Segment, Through 2023
Table 24: European Market for Genome Editing, by Product Segment, Through 2023
Table 25: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
Table 26: Rest of World Market for Genome Editing, by Product Segment, Through 2023
Table 27: Global Academic Research Market for Genome Editing, by Region, Through 2023
Table 28: Distribution of Genome Editing Patents and Patent Applications at USPTO, by Country, July 31, 2018
Table 29: Distribution of U.S. Genome Editing Patents and Patent Applications at USPTO, by State, July 31, 2018
Table 30: Distribution of Genome Editing Patents and Patent Applications at WIPO, by Patent Office, July 31, 2018
Table 31: Genome Editing Patents and Patent Applications at USPTO, by Application Year, July 31, 2018
Table 32: Genome Editing Patents and Patent Applications at WIPO, by Application Year, July 31, 2018
Table 33: Genome Editing Patents and Patent Applications at USPTO, by Technology, July 31, 2018
Table 34: NIH Funding for Gene/Genome Editing, by Year
Table 35: NIH-Funded Research Grants, by Year
Table 36: Global Drug Development Market for Genome Editing, by Region, Through 2023
Table 37: Global Plant Breeding Market for Genome Editing, by Region, Through 2023
Table 38: Global Market for Genome Editing, by Product Segment, Through 2023
Table 39: U.S. Market for Genome Editing, by Product Segment, Through 2023
Table 40: European Market for Genome Editing, by Product Segment, Through 2023
Table 41: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
Table 42: Rest of World Market for Genome Editing, by Product Segment, Through 2023

List of Figures
Summary Figure: Global Market for Genome Editing, by Region, 2017-2023
Figure 1: Distribution Share of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
Figure 2: Global Market for Genome Editing, by Region, 2017-2023
Figure 3: Global Genome Editing Market Share, by Region, 2017
Figure 4: Global Genome Editing Market Share, by Region, 2023
Figure 5: Global Genome Editing Market Share, by Application, 2017
Figure 6: Global Genome Editing Market Share, by Application, 2023
Figure 7: U.S. Genome Editing Market Share, by Application, 2017
Figure 8: U.S. Genome Editing Market Share, by Application, 2023
Figure 9: European Genome Editing Market Share, by Application, 2017
Figure 10: European Genome Editing Market Share, by Application, 2023
Figure 11: Asia-Pacific Genome Editing Market Share, by Application, 2017
Figure 12: Asia-Pacific Genome Editing Market Share, by Application, 2023
Figure 13: Global Genome Editing Market Share, by Technology, 2017
Figure 14: Global Genome Editing Market Share, by Technology, 2023
Figure 15: U.S. Genome Editing Market Share, by Technology, 2017
Figure 16: U.S. Genome Editing Market Share, by Technology, 2023
Figure 17: European Genome Editing Market Share, by Technology, 2017
Figure 18: European Genome Editing Market Share, by Technology, 2023
Figure 19: Asia-Pacific Genome Editing Market Share, by Technology, 2017
Figure 20: Asia-Pacific Genome Editing Market Share, by Technology, 2023
Figure 21: Global Genome Editing Market Share, by Product Type, 2017
Figure 22: Global Genome Editing Market Share, by Product Type, 2023
Figure 23: Global Genome Editing Services Market Share, by Region, 2017
Figure 24: Global Genome Editing Services Market Share, by Region, 2023
Figure 25: Global Genome Editing Market Share, by Product Segment, 2017
Figure 26: Global Genome Editing Market Share, by Product Segment, 2023
Figure 27: Global Academic Research Market Share of Genome Editing, by Region, 2017
Figure 28: Global Academic Research Market Share of Genome Editing, by Region, 2023
Figure 29: Genome Editing Patents and Patent Applications Share, by Technology, July 31, 2018
Figure 30: CRISPR Publications, by Year, August 3, 2018
Figure 31: ZFNs Publications, by Year
Figure 32: TALENs Publications, by Year
Figure 33: NIH Funding for Gene/Genome Editing, by Year
Figure 34: NIH-Funded Research Grants, by Year
Figure 35: Global Drug Development Market Share of Genome Editing, by Region, 2017
Figure 36: Global Drug Development Market Share of Genome Editing, by Region, 2023
Figure 37: Global Plant Breeding Market Share of Genome Editing, by Region, 2017
Figure 38: Global Plant Breeding Market Share of Genome Editing, by Region, 2023
Figure 39: Global Clinical Genome Editing Market Share, by Region, 2023
Figure 40: Global Genome Editing Market Share, by Product Segment, 2023

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Addgene
  • Agilent Technologies Inc.
  • Aldevron
  • Allele Biotechnology
  • American Type Culture Collection (Atcc)
  • Applied Stemcell Inc.
  • Arbor Biotechnologie Inc.
  • Astrazeneca
  • Atum (Dna2.0)
  • Australian Bioresources Ltd.
  • Axol Bioscience Ltd.
  • B-Mogen Biotechnologies Inc.
  • Beam Therapeutics
  • Bio-Rad Laboratories Inc.
  • Biocytogen
  • Biotools Co. Ltd.
  • Bluebird Bio
  • Calyxt Inc.
  • Canopy Biosciences
  • Caribou Biosciences Inc.
  • Caszyme
  • Cellecta Inc.
  • Cellectics S.A.
  • Cibus
  • Crispr Therapeutics
  • Desktop Genetics
  • Editas Medicine
  • Genecopoeia
  • Genewiz
  • Genscript
  • Horizon Discovery
  • Innovative Genomics Initiative
  • Integrated Dna Technologies
  • Intellia Therapeutics Inc.
  • Ixcells Biotechnologies
  • Juno Therapeutics
  • Lonza
  • Mammoth Biosciences
  • Merck Kgaa (Sigma-Aldrich)
  • New England Biolabs
  • Origene Technologies
  • Precision Biosciences Inc.
  • Recombinetics
  • Regeneron Pharmaceutals Inc.
  • Sangamo Biosciences
  • Solentim Inc.
  • Synthego
  • System Biosciences
  • Takara Bio Usa Inc. (Clontech)
  • Thermo Fisher Scientific
  • Toolgen Inc.
  • Trans Genic Inc.
  • Transomic Technologies Inc.
  • Transposagen Biopharmaceuticals Inc.
  • Vertex Pharmaceuticals Inc.
Note: Product cover images may vary from those shown
Adroll
adroll